Chemotherapy Current Events | Chemotherapy News | 2
|
| Page
2 of
25 |
498 Results |
|
|
|
Sort By:
Page Views | Date |
Study shows chemotherapy improves survival among older breast cancer patients
The average age of a woman diagnosed with breast cancer is 63, so it is critical to have effective proven, therapies for an older patient population. view more (2009-05-14)
Tablet is better all round for cancer patients
A drug to treat colon cancer is proving much more convenient than traditional chemotherapy, has fewer side effects - and a study of almost 2,000 patients has shown it is giving them a better chance of surviving the disease. view more (2007-10-09)
Survey reveals need for standardized oral chemotherapy prescribing practices, safeguards
Despite the widespread use of prescribing safeguards for infusion chemotherapy, few of those measures have been implemented with oral chemotherapy, according to a study led by researchers at Dana-Farber Cancer Institute. view more (2007-01-12)
Ginger quells cancer patients' nausea from chemotherapy
People with cancer can reduce post-chemotherapy nausea by 40 percent by using ginger supplements, along with standard anti-vomiting drugs, before undergoing treatment, according to scientists at the University of Rochester Medical Center. view more (2009-05-15)
Benefit of chemotherapy in breast cancer depends on estrogen-receptor status
When it comes to chemotherapy treatment for women whose breast cancer has spread to their lymph nodes, the estrogen status of their tumors matters. view more (2006-04-12)
New Herceptin results confirm impressive reduction in risk of cancer returning
New Herceptin results confirm impressive reduction in risk of cancer returning in women with aggressive form of early-stage breast cancer. view more (2005-09-14)
Cancer patients who receive neoadjuvant therapy followed by mastectomy may not need radiation
Early-stage breast cancer patients who exhibit limited lymph node involvement may not require post-surgery radiation therapy (RT) when they receive neoadjuvant chemotherapy before a mastectomy, according to researchers from The University of Texas M. D. Anderson Cancer Center. view more (2008-09-25)
Bisphenol A linked to chemotherapy resistance
Exposure to bisphenol A (BPA) may reduce the effectiveness of chemotherapy treatments, say University of Cincinnati (UC) scientists. view more (2008-10-09)
Study makes progress in zoning in on biomarkers for better colon cancer treatment
New research has yielded a clearer picture of which biomarkers could help doctors more precisely target the treatment of colon cancer, bringing closer the day when patients who will not benefit from chemotherapy are spared it, while those that will, get the more aggressive treatment they need. view more (2007-09-27)
Pneumatosis cystoids intestinalis after fluorouracil chemotherapy
The mechanism of pneumatosis cystoids intestinalis (PCI) is unclear. The mechanical and bacterial factors are most predominant causes of PCI. view more (2008-09-18)
Gene Test Could Reduce Unnecessary Treatment For Women With Breast Cancer (pp 340, 362)
In this week's issue of THE LANCET, US researchers describe how gene expression profiles could determine whether or not women with breast cancer would respond to docetaxel treatment. Women who are likely to be resistant to the drug could be given alternative treatment. Chemotherapy or hormonal treatment after surgery for breast cancer is crucial... view more... (2003-07-30)
Intraperitoneal chemotherapy administration prolongs survival for women with advanced ovarian cancer
A study featured in this month's edition of Gynecologic Oncology examines the challenges associated with the administration of intra-abdominal chemotherapy, also known as intraperitoneal (IP) chemotherapy. view more (2006-01-05)
Intense chemotherapy wards off recurrence in half of mantle cell lymphoma patients after seven years
More than half of younger mantle cell lymphoma patients who received an intensive regimen of chemotherapy as frontline treatment remain in remission seven years later, researchers at The University of Texas M. D. Anderson Cancer Center report today at the 50th annual meeting of the American Society of Hematology. view more (2008-12-10)
Blood Protein Plays Key Role In Reducing Chemotherapy-related Infection (pp 598, 614, 637)
Low concentrations of the blood protein mannose-binding lectin (MBL) are associated with prolonged fever in cancer patients treated with chemotherapy, conclude authors of two studies published in this week's issue of THE LANCET. Genetic identification of patients with low MBL concentrations and the potential for MBL-replacement therapy could... view more... (2001-08-22)
Many oncologists unaware of cancer clot risk
Patients receiving cancer treatments are at greater risk of blood clots, yet more than a quarter of oncologists do not recognise their clotting effects and preventive measures are rarely used, finds a study in this week’s BMJ. view more (2003-09-10)
Prediction model superior to traditional criteria in bladder treatment decision
A statistical model can accurately predict which patients will have poor outcomes after bladder surgery and can determine the need for chemotherapy. view more (2009-10-12)
NC State Researchers Find Soy May Aid in Treating Canine Cancers
Researchers at North Carolina State University are looking to soy as a way to make traditional canine cancer therapy more effective, less stressful for the dog and less costly for the owners. view more (2009-04-09)
Adverse effects of chemotherapy may be under-reported
Young breast cancer patients who receive chemotherapy may have a higher number of serious side effects than reported in clinical trials. view more (2006-08-16)
More older women with early stage breast cancer choose chemotherapy, GUMC researchers say
A new study examining treatment decision-making by older women with early stage breast cancer shows that 45 percent of women would choose to get chemotherapy after surgery -- a figure higher than the national average of women getting the additional treatment. view more (2009-05-15)
UAB Study Shows Drug May Fight Biliary Cancers
Laboratory studies by University of Alabama at Birmingham (UAB) researchers have shown that the drug triphendiol (NV-196) causes cell death in pancreatic and bile duct cancer cell lines, slows tumor growth and sensitizes tumors to chemotherapy treatments. view more (2008-04-16)
|
|
| Page
2 of
25 |
498 Results |
|
|
|
Sort By:
Page Views | Date |
|
